Private Advisor Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.06M | Buy |
10,451
+625
| +6% | +$205K | 0.01% | 846 |
|
|
2025
Q4 | $3.44M | Sell |
9,826
-121
| -1% | -$40.9K | 0.02% | 789 |
|
|
2025
Q3 | $3.21M | Sell |
9,947
-557
| -5% | -$173K | 0.02% | 803 |
|
|
2025
Q2 | $4.09M | Buy |
10,504
+534
| +5% | +$215K | 0.02% | 652 |
|
|
2025
Q1 | $4.34M | Buy |
9,970
+468
| +5% | +$188K | 0.03% | 588 |
|
|
2024
Q4 | $3.51M | Sell |
9,502
-2,311
| -20% | -$967K | 0.02% | 649 |
|
|
2024
Q3 | $6.14M | Sell |
11,813
-1,290
| -10% | -$689K | 0.04% | 451 |
|
|
2024
Q2 | $7.1M | Buy |
13,103
+876
| +7% | +$463K | 0.05% | 363 |
|
|
2024
Q1 | $6.34M | Sell |
12,227
-250
| -2% | -$124K | 0.05% | 387 |
|
|
2023
Q4 | $5.88M | Sell |
12,477
-272
| -2% | -$126K | 0.05% | 374 |
|
|
2023
Q3 | $5.55M | Buy |
12,749
+1,592
| +14% | +$722K | 0.05% | 363 |
|
|
2023
Q2 | $5.03M | Buy |
11,157
+1,475
| +15% | +$680K | 0.04% | 397 |
|
|
2023
Q1 | $4.45M | Sell |
9,682
-1,077
| -10% | -$513K | 0.04% | 417 |
|
|
2022
Q4 | $1.08M | Buy |
10,759
+1,008
| +10% | +$512K | 0.05% | 341 |
|
|
2022
Q3 | $4.43M | Sell |
9,751
-3,333
| -25% | -$1.59M | 0.05% | 367 |
|
|
2022
Q2 | $6.31M | Buy |
13,084
+204
| +2% | +$101K | 0.06% | 334 |
|
|
2022
Q1 | $6.33M | Buy |
12,880
+1,581
| +14% | +$723K | 0.05% | 361 |
|
|
2021
Q4 | $5.24M | Sell |
11,299
-1,939
| -15% | -$816K | 0.04% | 439 |
|
|
2021
Q3 | $4.94M | Buy |
13,238
+4,346
| +49% | +$1.65M | 0.03% | 516 |
|
|
2021
Q2 | $3.4M | Sell |
8,892
-10,338
| -54% | -$3.95M | 0.03% | 548 |
|
|
2021
Q1 | $6.9M | Buy |
19,230
+10,192
| +113% | +$3.28M | 0.07% | 292 |
|
|
2020
Q4 | $2.9M | Buy |
9,038
+825
| +10% | +$253K | 0.03% | 530 |
|
|
2020
Q3 | $2.19M | Buy |
8,213
+552
| +7% | +$149K | 0.03% | 523 |
|
|
2020
Q2 | $2.02M | Buy |
7,661
+352
| +5% | +$93.9K | 0.03% | 536 |
|
|
2020
Q1 | $1.66M | Sell |
7,309
-1,493
| -17% | -$407K | 0.03% | 494 |
|
|
2019
Q4 | $2.66M | Sell |
8,802
-1,008
| -10% | -$277K | 0.04% | 444 |
|
|
2019
Q3 | $2.42M | Buy |
9,810
+2,546
| +35% | +$698K | 0.04% | 483 |
|
|
2019
Q2 | $2.05M | Buy |
7,264
+3,570
| +97% | +$975K | 0.04% | 476 |
|
|
2019
Q1 | $1.06M | Buy |
3,694
+328
| +10% | +$94.9K | 0.02% | 636 |
|
|
2018
Q4 | $885K | Buy |
3,366
+982
| +41% | +$270K | 0.02% | 623 |
|
|
2018
Q3 | $653K | Sell |
2,384
-9,003
| -79% | -$2.34M | 0.01% | 876 |
|
|
2018
Q2 | $2.71M | Buy |
11,387
+9,493
| +501% | +$2.2M | 0.04% | 207 |
|
|
2018
Q1 | $417K | Sell |
1,894
-932
| -33% | -$219K | 0.02% | 741 |
|
|
2017
Q4 | $652K | Sell |
2,826
-1,214
| -30% | -$259K | 0.03% | 541 |
|
|
2017
Q3 | $770K | Sell |
4,040
-839
| -17% | -$160K | 0.02% | 677 |
|
|
2017
Q2 | $937K | Sell |
4,879
-406
| -8% | -$72.9K | 0.03% | 563 |
|
|
2017
Q1 | $524K | Buy |
5,285
+2,687
| +103% | +$427K | 0.01% | 805 |
|
|
2016
Q4 | $378K | Buy |
2,598
+683
| +36% | +$91.5K | 0.01% | 851 |
|
|
2016
Q3 | $235K | Sell |
1,915
-605
| -24% | -$78.1K | 0.01% | 941 |
|
|
2016
Q2 | $333K | Sell |
2,520
-2,660
| -51% | -$364K | 0.01% | 773 |
|
|
2016
Q1 | $682K | Buy |
+5,180
| New | +$692K | 0.03% | 469 |
|
Other funds holding ELV
VCM
VPM
Private Advisor Group's ELV Position: Q1 2026 in Review
Private Advisor Group increased its Elevance Health (ELV) stake by 6.4% in Q1 2026, buying an estimated $205K and bringing the position to 10,451 shares worth $3.06M. The position accounts for 0.01% of the portfolio, ranked #846.
Private Advisor Group first reported a position in ELV in Q1 2016 and has held it in 41 quarters since. The position peaked at $7.1M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Private Advisor Group held 10,451 shares of Elevance Health worth $3.06M as of Q1 2026.
- Private Advisor Group bought 625 Elevance Health shares in Q1 2026, an estimated $205K.
- Elevance Health made up 0.01% of Private Advisor Group's portfolio in Q1 2026, its #846 holding.
- Private Advisor Group first reported a position in Elevance Health in Q1 2016 and has held it in 41 quarters since.
- Private Advisor Group's Elevance Health position peaked at $7.1M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.